Sonoma Biotherapeutics
sonomabio.com · 112 people
- Open roles
- 1
- Remote
- 0
- Headcount
- 112
- Offices
- 2
About Sonoma Biotherapeutics
Sonoma Biotherapeutics is a South San Francisco and Seattle-based clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases by restoring balance to the immune system. Founded by pioneers in Treg biology and cell therapy, the company brings together leading expertise and proprietary methodologies for the discovery and development of disease modifying and curative therapies. Sonoma Bio has initiated two Phase 1 studies to evaluate the safety and proof-of-mechanism of the company’s lead Treg cell therapy candidate, SBT-77-7101, in patients with rheumatoid arthritis and hidradenitis suppurativa. The company has a partnership with Regeneron to discover, develop and commercialize novel regulatory T cell therapies. More information at www.sonomabio.com.
Markets
Offices
Backed by
Open roles at Sonoma Biotherapeutics
- 7 weeks ago
Apply on autopilot
Tell me once what you are looking for. Every morning I rank the whole catalog against your profile, pick the openings worth your time, and prepare a tailored resume and cover letter for each one.
Applications finish as drafts. Nothing is sent until you read it and press send. New accounts start with 500 free credits.
Counted from the job board Sonoma Biotherapeutics publishes. Refolk is not affiliated with Sonoma Biotherapeutics and does not handle their hiring.